41 Biotech Startups in Cambridge to Watch in 2024

Drug delivery platform.

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

Physiological upregulation therapy to treat neurodegenerative diseases.

Genomic data analysis platform.

AI platform to advance precision medicine clinical trials.

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

Anti-cancer drug developer.

DNA synthesis technology researcher.

Genomics company building safer cell and gene therapies.

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Epitopea is a transatlantic cancer immunotherapeutics company.

Deubiquitylating enzyme (DUB) drug discovery and development platform.

Drug manufacturer.

PetMedix is a pet therapeutics startup.

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

HexagonFab is the biological sensor for rapid and cost-effective detection of biological substances.

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

Plant-based biodegradable material producer.

Transine Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Clinical stage studies to discover biomarkers to improve medical diagnosis.

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

The food chain is broken. Our technology fixes it.

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.

Congenica is a biotechnology company that provides a diagnostic decision support platform.

Legacy is a digital fertility clinic for men, founded at Harvard & backed by Y Combinator, FirstMark Capital, Bain Capital and celebrities.

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology.

Entomics is a biotechnology platform that transforms food waste into sustainable, renewable resources with the use of insects.

DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.

A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.

An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.